Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer’s disease mouse model
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Repeated scanning ultrasound in the absence of a therapeutic agent removes amyloid-β and restores memory in an Alzheimer’s disease mouse model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our results support previous studies showing improved behaviour in AD mouse models associated with enhanced microglial amyloid plaque phagocytosis in response to scanning ultrasound69, and treatment with IL-33 that signals exclusively via MyD8870.”
From Transcriptional signature in microglia associated with Aβ plaque phagocytosis (2021) · cites this paper as [69]
Citations
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769
RetractedSoluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 1×
“An entire series of sections was processed for Campbell-Switzer silver staining (36) using a protocol available online at http://neuroscienceassociates.”
MethodScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“Ab is elevated in the AD brain because of the increased production of this peptide and its impaired removal (4, 5).”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821 · cited 1×
“At the age of 12 to 13 months, APP23 mice have a substantial plaque burden and spatial memory deficits (17).”
BackgroundSelf-citationTwo amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507
Amyloid-β and tau--a toxic pas de deux in Alzheimer’s disease
Ittner, L. M., & Götz, J. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn2967 · Cited by 1,269
Self-citationAlzheimer’s disease: Clinical trials and drug development
Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217 · cited 1×
“Recent therapeutic strategies have targeted both processes (6), including the inhibition of secretase enzymes to reduce Ab production, as well as active and, in particular, passive immunization approaches for boosting Ab clearance.”
The secretases: enzymes with therapeutic potential in Alzheimer disease
De Strooper, B., Vassar, R., & Golde, T. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.218 · Cited by 799 · cited 1×
“Inhibition of secretases affects additional substrates with potential off-target effects (7), and passive immunization may be costly once effectiveness is demonstrated in clinical trials (8).”
Background
Cited by
Items 101–200 of 514
Pacia, C. P., Yuan, J., Yue, Y., Xu, L., Nazeri, A., Desai, R. R., Gach, H. M., Wang, X., Talcott, M., Chaudhuri, A. A., et al. (2021) · Theranostics · doi:10.7150/thno.65597 · Cited by 74
Xhima, K., Markham-Coultes, K., Nedev, H., Heinen, S., Saragovi, H. U., Hynynen, K., & Aubert, I. (2020) · Science Advances · doi:10.1126/sciadv.aax6646 · Cited by 69
“In several mouse models of AD, FUS-mediated BBB opening reduced amyloid and tau pathology, even in the absence of drug delivery (26, 38, 39, 42, 43).”
BackgroundHsu, P.-H., Lin, Y.-T., Chung, Y.-H., Lin, K.-J., Yang, L.-Y., Yen, T.-C., & Liu, H.-L. (2018) · Scientific Reports · doi:10.1038/s41598-018-31071-8 · Cited by 70
Wang, C., Lu, J., Sha, X., Qiu, Y., Chen, H., & Yu, Z. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00935-z · Cited by 70
Bae, S., Liu, K., Pouliopoulos, A. N., Ji, R., Jiménez-Gambín, S., Yousefian, O., Kline-Schoder, A. R., Batts, A. J., Tsitsos, F. N., Kokossis, D., et al. (2024) · Theranostics · doi:10.7150/thno.94206 · Cited by 70
“This difference may be attributed to the Preclinical studies have reported improved cognitive function after FUS [14,57,58] and a clinical study using MRgFUS has shown a cognitive improvement measured by the caregiver-administered neuropsychiatric inventory (CGA-NPI) [17].”
Weintraub, D., & Elias, W. J. (2016) · Movement Disorders · doi:10.1002/mds.26599 · Cited by 73
“In separate studies, Burgess and coworkers and Leinenga and Gotz demonstrated, in a mouse model, that repetitively disrupting the BBB in the hippocampus allowed for clearance of amyloid plaques and improvement in functional performance along with increased neuronogenesis.(70,71) This work holds tremendous potential fo…”
BackgroundGuo, Y., Lee, H., Kim, C., Park, C., Yamamichi, A., Chuntova, P., Gallus, M., Bernabéu, M. O., Okada, H., Jo, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52329-y · Cited by 82
Facilitation of Drug Transport across the Blood–Brain Barrier with Ultrasound and Microbubbles
Meairs, S. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7030275 · Cited by 67
“These effects have recently been duplicated by another research group using a different mouse model of Alzheimer’s [89].”
ResultWu, S.-Y., Sánchez, C. S., Samiotaki, G., Buch, A., Ferrera, V. P., & Konofagou, E. E. (2016) · Scientific Reports · doi:10.1038/srep37094 · Cited by 71
Lee, E., Fomenko, A., & Lozano, A. M. (2019) · Journal of Korean Neurosurgical Society · doi:10.3340/jkns.2018.0180 · Cited by 73
Poon, C., Pellow, C., & Hynynen, K. (2021) · Theranostics · doi:10.7150/thno.52710 · Cited by 68
“In addition to enhanced agent delivery [3-8], FUS+MB exposure has been shown to induce biological effects such as neurogenesis in the dentate gyrus [9, 10], glial cell activation [11], and a reduction in β-amyloid (Aβ) plaque load in transgenic mouse models of Alzheimer’s disease (AD) [12-15].”
BackgroundTreatment of Alzheimer Disease With CT Scans: A Case Report
Cuttler, J. M., Moore, E. R., Hosfeld, V. D., & Nadolski, D. L. (2016) · Dose-Response · doi:10.1177/1559325816640073 · Cited by 69
“A study in Australia on the use of ultrasound energy removed Ab and restored memory in an AD mouse model.(26) Since mechanical stress is a method of upregulating adaptive protective systems, it is not surprising that this approach succeeded.”
BackgroundO'Reilly, M. A., Jones, R. M., Barrett, E., Schwab, A., Head, E., & Hynynen, K. (2017) · Theranostics · doi:10.7150/thno.20621 · Cited by 67
“Preliminary histological evidence suggests that ultrasound treatments in a natural disease model is safe and in 3/5 of our animals, particularly in the repeated treatment condition, may also impact plaque pathology as has been seen in transgenic mouse models of AD [18, 19].”
BackgroundStobiecka, M., Dworakowska, B., Jakieła, S., Łukasiak, A., Chałupa, A., & Zembrzycki, K. (2016) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2016.04.176 · Cited by 67
Wasielewska, J. M., & White, A. R. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03185-2 · Cited by 69
Roberts, B. R., Doecke, J. D., Rembach, A., Yévenes, L. F., Fowler, C. J., McLean, C., Lind, M., Volitakis, I., Masters, C. L., Bush, A. I., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0390-8 · Cited by 71
“A non-invasive scanning ultrasound approach to temporarily open the BBB in the APP23 transgenic AD mouse model was shown to be effective in clearing accumulated Aβ [40], and a number of clinical trials testing the safety and efficacy of this approach, predominantly for drug delivery, are currently ongoing [41].”
MethodYıldırım, A., Shi, D., Roy, S., Blum, N. T., Chattaraj, R., Cha, J. N., & Goodwin, A. P. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b15368 · Cited by 67
Fischell, J., & Fishman, P. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.747726 · Cited by 56
“Several studies have utilized SUS in the context of treating NDDs. Specifically, two studies investigated the delivery of anti-amyloid (Leinenga and Götz, 2015) and anti-tau (Nisbet et al., 2017) antibodies via SUS in animal models of AD.”
BackgroundLi, H., Sun, J., Zhang, D., Omire-Mayor, D., Lewin, P. A., & Tong, S. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.02.008 · Cited by 69
Construction of Silica‐Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine
Zhou, Y., Han, X., Jing, X., & Chen, Y. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700646 · Cited by 67
Safety and Efficacy of Scanning Ultrasound Treatment of Aged APP23 Mice
Leinenga, G., & Götz, J. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00055 · Cited by 65
“…the brain where they ameliorate the two defining pathologies of AD, Aβ and tau deposition, by an incompletely understood Frontiers in Neuroscience | www.frontiersin.org 7 February 2018 | Volume 12 | Article 55 mechanism that involves microglia (Jordão et al., 2010, 2013; Leinenga and Götz, 2015).”
BackgroundMethodSelf-citationSinharay, S., Tu, T., Kovacs‐Balint, Z., Schreiber-Stainthorp, W., Sundby, M., Zhang, X., Papadakis, G. Z., Reid, W. C., Frank, J. A., & Hammoud, D. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1543-z · Cited by 68
Perspectives on Recent Progress in Focused Ultrasound Immunotherapy
Sheybani, N., & Price, R. J. (2019) · Theranostics · doi:10.7150/thno.37131 · Cited by 68
“Ultrasound treatment has been demonstrated to confer clearance of amyloid plaques in transgenic models of Alzheimer’s disease, independent of drug or gene delivery [28,29].”
BackgroundSemyachkina-Glushkovskaya, O. V., Postnov, D. E., Penzel, T., & Kurths, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176293 · Cited by 67
Blackmore, D. G., Turpin, F. R., Palliyaguru, T., Evans, H. T., Chicoteau, A., Lee, W., Pelekanos, M., Nguyen, N., Song, J. H., Sullivan, R., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01129-7 · Cited by 65
“What are the implications of our study for human conditions of memory impairment? Whereas therapeutic ultrasound with MBs (SUS) is currently being explored as a treatment modality for AD because of its effects on clearing protein aggregates due to the uptake of blood-borne therapeutic factors [3, 4, 47], our data sugg…”
BackgroundMethodInfluentialSelf-citationBrain Mechanisms of COVID-19-Sleep Disorders
Semyachkina-Glushkovskaya, O. V., Mamedova, A., Telnova, V., Klimova, M., Saranceva, E. I., Ageev, V., Yu, T., Zhu, D. Y., Penzel, T., & Kurths, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136917 · Cited by 76
Current and emerging brain applications of MR-guided focused ultrasound
Meng, Y., Suppiah, S., Mithani, K., Solomon, B., Schwartz, M. L., & Lipsman, N. (2017) · Journal of Therapeutic Ultrasound · doi:10.1186/s40349-017-0105-z · Cited by 66
“Reductions in plaque number and surface area after ultrasound mediated BBB opening alone were replicated by another research group in APP23 transgenic mouse line [84], along with behavioral improvement as well as a five-fold reduction of Aβ monomer and two-fold reduction of Aβ trimer, which may have an even greater ro…”
MethodLin, C., Tsai, C.-H., Feng, L.-Y., Chai, W., Lin, C.-J., Huang, C.-Y., Wei, K., Yeh, C., Chen, C., & Liu, H.-L. (2019) · Brain stimulation · doi:10.1016/j.brs.2019.04.011 · Cited by 64
Efficacy of gene delivery to the brain using AAV and ultrasound depends on serotypes and brain areas
Kofoed, R. H., Dibia, C. L., Noseworthy, K., Xhima, K., Vacaresse, N., Hynynen, K., & Aubert, I. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.048 · Cited by 67
Liu, X., Naomi, S. S. M., Sharon, W. L., & Russell, E. J. (2021) · Aging and disease · doi:10.14336/ad.2021.0510 · Cited by 52
“Activated astrocytes and microglia internalize Aβ and contribute to plaque reduction [15, 16, 34].”
BackgroundPelekanos, M., Leinenga, G., Odabaee, M., Odabaee, M., Saifzadeh, S., Steck, R., & Götz, J. (2018) · Theranostics · doi:10.7150/thno.22852 · Cited by 59
“To visualize BBB opening, we used Evans blue extravasation as done by us previously [19].”
BackgroundMethodSelf-citationBlood–brain barrier opening with focused ultrasound in experimental models of Parkinson's disease
Karakatsani, M. E., Blesa, J., & Konofagou, E. E. (2019) · Movement Disorders · doi:10.1002/mds.27804 · Cited by 60
Wu, H., Zhou, Y., Xu, L., Tong, L., Wang, Y., Liu, B., Yan, H., & Sun, Z. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.706105 · Cited by 65
Jiang, T., Li, Y., He, S., Huang, N., Du, M., Zhai, Q., Pu, K., Wu, M., Yan, C., Ma, Z., et al. (2023) · eBioMedicine · doi:10.1016/j.ebiom.2023.104653 · Cited by 57
“41 The maze consisted of an isolated triangular central area and three identical arms at an angle of 120.”
Nisbet, R. M., & Götz, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179907 · Cited by 61
Self-citationTargeting Alzheimer's disease with gene and cell therapies
Loera‐Valencia, R., Piras, A., Ismail, M.-A.-M., Manchanda, S., Eyjolfsdottir, H., Saido, T. C., Johansson, J., Eriksdotter, M., Winblad, B. G., & Nilsson, P. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12759 · Cited by 60
Beccaria, K., Sabbagh, A., de Groot, J., Canney, M. S., Carpentier, A. C., & Heimberger, A. B. (2020) · Journal of Neuro-Oncology · doi:10.1007/s11060-020-03425-8 · Cited by 59
Sonoselective transfection of cerebral vasculature without blood–brain barrier disruption
Gorick, C. M., Mathew, A. S., Garrison, W. J., Thim, E. A., Fisher, D. G., Copeland, C. A., Song, J., Klibanov, A. L., Miller, G. W., & Price, R. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1914595117 · Cited by 57
“Widespread BBB disruption has even been shown to reduce amyloid-beta plaques in a mouse model of Alzheimer ’ s disease (55).”
CuII Binding Properties of N-Truncated Aβ Peptides: In Search of Biological Function
Stefaniak, E., & Bal, W. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01399 · Cited by 61
Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain
Bajracharya, R., Caruso, A. C., Vella, L. J., & Nisbet, R. M. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122014 · Cited by 54
Current state of clinical ultrasound neuromodulation
Matt, E., Radjenovic, S., Mitterwallner, M., & Beisteiner, R. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1420255 · Cited by 60
Sierra, C., Acosta, C., Chen, C., Wu, S.-Y., Karakatsani, M. E., Bernal, M., & Konofagou, E. E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16652630 · Cited by 53
Phospholipid Capped Mesoporous Nanoparticles for Targeted High Intensity Focused Ultrasound Ablation
Yıldırım, A., Chattaraj, R., Blum, N. T., Shi, D., Kumar, K., & Goodwin, A. P. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700514 · Cited by 55
Fanaee‐Danesh, E., Gali, C. C., Tadić, J., Zandl‐Lang, M., Kober, A. C., Agujetas, V. R., de Dios, C., Tam‐Amersdorfer, C., Stracke, A., Albrecher, N. M., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.04.019 · Cited by 53
Sonogenetic-Based Neuromodulation for the Amelioration of Parkinson’s Disease
Fan, C.-H., Wei, K.-C., Chiu, N.-H., Liao, E.-C., Wang, H.-C., Wu, R.-Y., Ho, Y.-J., Chan, H.-L., Wang, T.-S. A., Huang, Y.-Z., et al. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00886 · Cited by 51
Chen, S., Nazeri, A., Baek, H., Ye, D., Yang, Y., Yuan, J., Rubin, J. B., & Chen, H. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x211046129 · Cited by 57
“However, this hypothesis is contrary to the observation that AQP4 protein levels reduced after FUSþMB due to the loss of astrocytic endfeet.(119) The role of astrocyte end-feet and AQP4 remains unclear in the regulation of solute transport within parenchyma extracellular spaces.”
ResultEnhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model
Kong, C., Yang, E.-J., Shin, J., Park, J., Kim, S.-H., Park, S.-W., Chang, W. S., Lee, C.-H., Kim, H., Kim, H.-S., et al. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00333-x · Cited by 47
“A previous report by others focused on the effects of a scanning ultrasound on the delivery of Adu into the brain and demonstrated that in APP23 mice, both the Adu only and scanning ultrasound only groups reduced the total plaque area in the hippocampus with no additive effect observed with the combination treatment o…”
MethodSaikia, J., Pandey, G., Sasidharan, S., Antony, F., Nemade, H. B., Kumar, S., Chaudhary, N., & Ramakrishnan, V. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00490 · Cited by 53
Graphene oxide enhances β-amyloid clearance by inducing autophagy of microglia and neurons
Li, X., Li, K., Chu, F., Huang, J., & Yang, Z. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109126 · Cited by 51
Zhu, L., Nazeri, A., Pacia, C. P., Yue, Y., & Chen, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0234182 · Cited by 54
“As a drug delivery technique, it has been explored in preclinical studies for the treatment of various neurological diseases [17,18], such as primary brain tumors [19–21], metastatic brain cancers [22], Alzheimer’s disease [23], and Parkinson’s disease [24].”
MethodMcDonough, I. M., Festini, S. B., & Wood, M. M. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101133 · Cited by 58
Transcranial Ultrasound Innovations Ready for Broad Clinical Application
Beisteiner, R., & Lozano, A. M. (2020) · Advanced Science · doi:10.1002/advs.202002026 · Cited by 53
Transcranial Focused Ultrasound Stimulation of Periaqueductal Gray for Analgesia
Zhang, T., Wang, Z., Liang, H., Wu, Z., Li, J., Ou-Yang, J., Yang, X., Peng, Y. B., & Zhu, B. (2022) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2022.3162073 · Cited by 55
“found that scanning ultrasound could restore the memory of Alzheimer’s disease [34]; in 2018, D.”
BackgroundZhang, J., Zhou, H., Yang, J., Jia, J., Niu, L., Sun, Z., Shi, D., Meng, L., Qiu, W., Wang, X., et al. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13463 · Cited by 55
Alecou, T., Giannakou, M., & Damianou, C. (2017) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14256 · Cited by 45
Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
Fuster-Matanzo, A., Hernández, F., & Ávila, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030645 · Cited by 52
“In this way, it has been recently suggested that the use of sound waves could enhance BBB permeability, thereby facilitating the delivery of tau antibodies to the brain [124].”
BackgroundChu, F., Li, K., Li, X., Xu, L., Huang, J., & Yang, Z. R. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03167-z · Cited by 52
Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patients
Rincón-Torroella, J., Khela, H. S., Bettegowda, A., & Bettegowda, C. (2021) · Journal of Neuro-Oncology · doi:10.1007/s11060-021-03837-0 · Cited by 53
Focused ultrasound-assisted delivery of immunomodulating agents in brain cancer
Memari, E., Khan, D. S., Alkins, R. D., & Helfield, B. L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.034 · Cited by 51
The road ahead to successful BBB opening and drug-delivery with focused ultrasound
López‐Aguirre, M., Castillo-Ortiz, M., Viña-González, A., Blesa, J., & Pineda‐Pardo, J. A. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.006 · Cited by 59
Kline-Schoder, A. R., Chintamen, S., Willner, M. J., DiBenedetto, M. R., Noel, R. L., Batts, A. J., Kwon, N., Zacharoulis, S., Wu, C.-C., Menon, V., et al. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01107-0 · Cited by 45
“Treatment with FUS BBB opening has shown promise, not only as a method of drug delivery across the BBB but also as an effective immuno-therapeutic methodology to ameliorate disease pathology and restore behavioural deficits in neurological disease 3,4,12,13 .”
Picosecond dissociation of amyloid fibrils with infrared laser: A nonequilibrium simulation study
Man, V. H., Derreumaux, P., Li, M. S., Roland, C., Sagui, C., & Nguyen, P. H. (2015) · The Journal of Chemical Physics · doi:10.1063/1.4933207 · Cited by 48
Focused ultrasound mitigates pathology and improves spatial memory in Alzheimer's mice and patients
Karakatsani, M. E., Ji, R., Murillo, M. F., Kugelman, T., Kwon, N., Lao, Y.-H., Liu, K., Pouliopoulos, A. N., Honig, L. S., Duff, K. E., et al. (2023) · Theranostics · doi:10.7150/thno.79898 · Cited by 40
“One prominent mechanism for the amyloid clearance from the brain is that FUS can directly trigger the innate immune response and activate microglia, since microglia have been found to engulf the amyloid plaques following sonication [19,24].”
BackgroundInfluentialAmanatkar, H. R., Papagiannopoulos, B., & Grossberg, G. T. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1194203 · Cited by 50
Endothelial Cells, First Target of Drug Delivery Using Microbubble-Assisted Ultrasound
Presset, A., Bonneau, C., Sasaoka, K., Nadal‐Desbarats, L., Mitsuyoshi, T., Bouakaz, A., Kudo, N., Escoffre, J., & Sasaki, N. (2020) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2020.03.013 · Cited by 48
Jones, R. M., & Hynynen, K. (2018) · British Journal of Radiology · doi:10.1259/bjr.20180601 · Cited by 50
“Prog Biophys Mol Biol 2007; 93(13): 314–30.”
Focused ultrasound as a novel strategy for Alzheimer disease therapeutics
Meng, Y., Volpini, M., Black, S. E., Lozano, A. M., Hynynen, K., & Lipsman, N. (2017) · Annals of Neurology · doi:10.1002/ana.24933 · Cited by 45
“Recent evidence in transgenic APP23 mice demonstrated significant microglia activation, reduction of plaque surface area, and a 5fold decrease in Ab monomer and oligomers following 9 weekly treatments (Fig 2).(71) Similar to MRgFUS experiments, sonication with SUS also led to rescued hippocampus-dependent spatial lear…”
MethodFocused ultrasound in Parkinson's disease: A twofold path toward disease modification
Foffani, G., Trigo‐Damas, I., Pineda‐Pardo, J. A., Blesa, J., Rodríguez‐Rojas, R., Martínez‐Fernández, R., & Obeso, J. A. (2019) · Movement Disorders · doi:10.1002/mds.27805 · Cited by 49
“In fact, FUS BBB opening per se induces microglial activation and an inflammatory response.(144,149) Inflammation and microglial activation are unequivocally associated with PD, but whether they are the cause or the consequence of neurodegeneration is unclear.”
BackgroundThe crosstalk between brain and periphery: Implications for brain health and disease
Gonçalves, R. A., & Felice, F. G. D. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108728 · Cited by 48
Ultrasonic technologies in imaging and drug delivery
Ho, Y.-J., Huang, C., Fan, C., Liu, H., & Yeh, C. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03904-9 · Cited by 48
“employed MB-ultrasound to open a wide area of the BBB and observed an apparent plaque burden reduction of up to 75%, with identification of the pathway that activates microglia to speed up clearance of amyloid plaque, and a consequent improvement in memory and behavioral performance [177].”
MethodFocused ultrasound gene delivery for the treatment of neurological disorders
Kofoed, R. H., & Aubert, I. (2024) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.12.006 · Cited by 46
Brain Glymphatic/Lymphatic Imaging by MRI and PET
Lee, D. S., Suh, M., Sarker, A. K., & Choi, Y. (2020) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-020-00665-4 · Cited by 46
Treatment of Movement Disorders With Focused Ultrasound
Fishman, P. S., & Frenkel, V. (2017) · Journal of Central Nervous System Disease · doi:10.1177/1179573517705670 · Cited by 44
Ultrasound delivery of a TrkA agonist confers neuroprotection to Alzheimer-associated pathologies
Xhima, K., Markham-Coultes, K., Hahn Kofoed, R., Saragovi, H. U., Hynynen, K., & Aubert, I. (2022) · Brain · doi:10.1093/brain/awab460 · Cited by 43
“1H), consistent with findings in APP23 transgenic mice with early-stage pathology and no underlying impairment in these tasks.(53) We also report comparable spatial learning and memory in the Barnes maze relative to untreated TgCRND8 mice (Fig.”
BackgroundShi, J.-S., Zhang, W., Wu, Q., Lu, Y.-L., Gong, Q., & Zhang, F. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.211193 · Cited by 44
Blackmore, D. G., Turpin, F., Mohamed, A. Z., Zong, F., Pandit, R., Pelekanos, M., Nasrallah, F., Sah, P., Bartlett, P. F., & Götz, J. (2018) · Theranostics · doi:10.7150/thno.27941 · Cited by 42
“Instead, the hippocampus-dependent APA paradigm was chosen, a test which we had previously demonstrated to be suitable for assessing the impact of ultrasound-mediated BBB opening on cognition in Alzheimer's mice [15].”
InfluentialSelf-citationChen, L., Sutharsan, R., Lee, J. L., Cruz, E., Asnicar, B., Palliyaguru, T., Wasielewska, J. M., Gaudin, A., Song, J. H., Leinenga, G., et al. (2022) · Theranostics · doi:10.7150/thno.65539 · Cited by 45
“Biologically inert microbubbles were prepared in-house as described previously [29, 30].”
BackgroundMethodSelf-citationKong, C., Ahn, J. W., Kim, S., Park, J. Y., Na, Y. C., Chang, J. W., Chung, S., & Chang, W. S. (2023) · Brain stimulation · doi:10.1016/j.brs.2023.05.014 · Cited by 47
Focused Ultrasound for Noninvasive, Focal Pharmacologic Neurointervention
Wang, J. B., Ianni, T. D., Vyas, D. B., Huang, Z., Park, S., Hosseini-Nassab, N., Aryal, M., & Airan, R. D. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00675 · Cited by 45
Choi, H. J., Han, M., Seo, H., Park, C. Y., Lee, E., & Park, J. Y. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00402-3 · Cited by 45
“Although recent studies have reported the activation of neuroglial cells in response to FUS-BBBD [13, 28, 44], the relationship between glial cell polarization and ultrasound-mediated mechanical bioeffects remain unclear.”
BackgroundBaker, S. L., & Götz, J. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0300-0 · Cited by 44
“Aggregation was assessed by reactivity with thioflavin-S that detects β-pleated sheet structures [27].”
MethodSelf-citationde Koning, L. A., Vazquez-Matias, D. A., Beaino, W., Vugts, D. J., van Dongen, G. A. M. S., van der Flier, W. M., Ries, M. G., van Vuurden, D. G., Vijverberg, E. G. B., & van de Giessen, E. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100204 · Cited by 49
“Several preclinical studies investigating the effects of FUS BBB opening have shown that FUS alone can reduce amyloid pathology in AD mouse models[ 25 , 28 , 30–32 ].”
Sonochemistry‐Assembled Stimuli‐Responsive Polymer Microcapsules for Drug Delivery
Li, Z., Wang, Z., Du, X., Shi, C., & Cui, X. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701326 · Cited by 44
Sun, T., Shi, Q., Zhang, Y., Power, C., Hoesch, C., Antonelli, S., Schroeder, M. K., Caldarone, B. J., Taudte, N., Schenk, M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.037 · Cited by 42
Low-intensity focused ultrasound for the treatment of brain diseases: safety and feasibility
Toccaceli, G., Barbagallo, G., & Peschillo, S. (2019) · Theranostics · doi:10.7150/thno.31765 · Cited by 39
“The anti-amyloid effect is confirmed by other studies that showed a significant improvement of cognitive tasks in tested animals and, at the same time, a reduction in β-amyloid plaques and an improvement of neurogenesis in the sonicated brain areas [6, 7, 8, 9].”
ResultBatts, A. J., Ji, R., Noel, R. L., Kline-Schoder, A. R., Bae, S., Kwon, N., & Konofagou, E. E. (2023) · Theranostics · doi:10.7150/thno.76199 · Cited by 38
“While the aforementioned FUS configurations are capable of inducing BBB openings in the same subject within a single treatment session, most require physical translation of the transducer to each target, creating inconsistencies in cavitation activity between targets due to clearance of microbubbles from the vasculatu…”
BackgroundWasielewska, J. M., Chaves, J. C. S., Johnston, R. L., Milton, L. A., Hernández, D., Chen, L., Song, J., Lee, W., Leinenga, G., Nisbet, R. M., et al. (2022) · Theranostics · doi:10.7150/thno.72685 · Cited by 41
“causes intravenously injected MBs to expand and contract, and when in contact with the BBB, exert a force that results in the loosening of tight junctions leading to transient BBB opening [17].”
BackgroundSelf-citationTsoy, A., Saliev, T. M., Abzhanova, E., Turgambayeva, A., Kaiyrlykyzy, A., Akishev, M., Saparbayev, S. S., Umbayev, B. A., & Askarova, S. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.03.058 · Cited by 40
Vagenknecht, P., Luzgin, A., Ono, M., Ji, B., Higuchi, M., Noaín, D., Maschio, C., Sobek, J., Chen, Z., Konietzko, U., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05708-w · Cited by 42
New horizons for focused ultrasound (FUS) – therapeutic applications in neurodegenerative diseases
Miller, D. B., & O'Callaghan, J. P. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.012 · Cited by 40
Sattiraju, A., Xiong, X.-B., Pandya, D. N., Wadas, T. J., Xuan, A., Sun, Y., Jung, Y., Sai, K. K. S., Dorsey, J. F., Li, K. C., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0907 · Cited by 39
Focused Ultrasound in Neuroscience. State of the Art and Future Perspectives
Giammalva, G. R., Gagliardo, C., Marrone, S., Paolini, F., Gerardi, R. M., Umana, G. E., Yağmurlu, K., Chaurasia, B. K., Scalia, G., Midiri, F., et al. (2021) · Brain Sciences · doi:10.3390/brainsci11010084 · Cited by 41
“Since microglial activation, the more significant beta-amyloid could be internalized in lysosomes, leading to improved memory functions in mouse models of AD [80].”
BackgroundJameel, A., Bain, P. G., Nandi, D., Jones, B., & Gedroyc, W. M. W. (2021) · Expert Review of Medical Devices · doi:10.1080/17434440.2021.1921572 · Cited by 39
“[39,40] MRgFUS treatments with ExAblate 4000 are currently confined to relatively deep and central targets within the brain; this to ensure adequate energy reaches the target site from”
BackgroundHu, Y., Yang, G., Liang, X.-S., Ding, X.-S., Xu, D.-E., Li, Z. Y., Ma, Q., Chen, R., & Sun, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1117188 · Cited by 41
“observed no change in inflammatory markers in the brains of aged APP23 mice after ultrasound stimulation (139).”
BackgroundCutler, S. J., & Ilinca, C. (2016) · Journal of Aging and Health · doi:10.1177/0898264316674535 · Cited by 37
The use of nonhuman primate models to understand processes in Parkinson’s disease
Blesa, J., Trigo‐Damas, I., del Rey, N. L., & Obeso, J. A. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1715-x · Cited by 41
“Therapeutic use of ultrasound has the potential to address some of the issues surrounding the treatment of PD and other neurodegenerative diseases, like Alzheimer’s disease (Leinenga and Gotz 2015; Leinenga et al. 2016).”
BackgroundProtocol for Short- and Longer-term Spatial Learning and Memory in Mice
Willis, E. F., Bartlett, P. F., & Vukovic, J. (2017) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2017.00197 · Cited by 39
“One such behavioral task is the active place avoidance (APA) task, which assesses hippocampal-dependent spatial learning and memory (Cimadevilla et al., 2000b, 2001a; Vukovic et al., 2013; Leinenga and Gotz, 2015; Cleland et al., 2017).”
Background3D Multi-Resolution Optical Flow Analysis of Cardiovascular Pulse Propagation in Human Brain
Rajna, Z., Raitamaa, L., Tuovinen, T., Heikkilä, J., Kiviniemi, V. J., & Seppänen, T. (2019) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2019.2904762 · Cited by 39
“To support this, two recent studies have shown that therapeutically increasing the brain amyloid clearance by momentary opening of the blood brain barrier with focused ultrasound (FUS), can remove most of the protein accumulations and restore the memory performance of treated dementia model mice [7], [8].”
BackgroundRojas, A. V., Maisuradze, N., Kachlishvili, K., Scheraga, H. A., & Maisuradze, G. G. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00331 · Cited by 36
Pascal, A., Li, N., Lechtenberg, K., Rosenberg, J., Airan, R., James, M., Bouley, D., & Pauly, K. (2020) · Nanotheranostics · doi:10.7150/ntno.49898 · Cited by 29
Metadata
- Authors
- Leinenga, G., & Götz, J.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Götz, Jürgen
- Venue
- Science Translational Medicine
- Published
- 2015-03-11
- Volume
- 7
- Issue
- 278
- Pages
- 278ra33-278ra33
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2169076271
- Cited by
- 498
- References
- 40
- Citations by year
- 2026: 24 · 2025: 39 · 2024: 40 · 2023: 50 · 2022: 41 · 2021: 52 · 2020: 51 · 2019: 40 · 2018: 44 · 2017: 55 · 2016: 36 · 2015: 25
- FWCI
- 39.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Australian Research Council (DP130101932)
- National Health and Medical Research Council of Australia (APP1037746, APP1003150)
- ARC Linkage Infrastructure, Equipment, and Facilities (LE130100078)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid-beta, non-pharmacological treatment, amyloid plaque clearance, microglia, memory recovery, mouse model
- MeSH terms
- Albumins, Alzheimer Disease, Animals, Blood-Brain Barrier, Cell Count, Disease Models, Animal, Humans, Inflammation, Lysosomes, Memory, Mice, Inbred C57BL, Mice, Transgenic, Phagocytosis, Ultrasonography, Ultrasonics, Amyloid beta-Peptides, Microglia, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.